Flash glucose monitoring in older patients with memory problems

Not Applicable

Completed

• Conditions: Diabetes mellitus; Nutritional, Metabolic, Endocrine; Metabolic and Endocrine/ Diabetes mellitus

• Registration Number: ISRCTN29516623
• Lead Sponsor: Alzheimer’s Society

Brief Summary

2019 results in: doi: 10.1136/bmjopen-2019-032037 (added 15/01/2020)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-01-09
• Study Completion: 2020-01-31
• Last Update Posted: 3 February 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 17

Inclusion Criteria

1. Patients aged 65 and older (male or female)
2. Type 1 or Type 2 diabetes mellitus
3. On glucose-lowering medication
4. Abbreviated Mini-Mental Test (AMT) score equal or less than 8 (out of 10) or already has formal diagnosis of dementia

Exclusion Criteria

1. Treatment with metformin only
2. Not willing to participate
3. Terminal illness (less than one-year life expectancy)
4. AMT>8
5. Evidence of bruising, bleeding, cellulitis and/or skin tears on the upper arms

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> 1. Numbers of potentially eligible patients who meet the selection criteria<br> 2. Number of participants subsequently recruited into the study at 12 months<br> 3. Extent of capture of blood glucose readings<br> 4. Attrition rate and reasons for withdrawal<br> 5. Adverse events<br>

Secondary Outcome Measures

Name	Time	Method
<br> The following patient outcomes will be collected by means of a qualitative interview at the end of the study period (after wearing the sensor for two weeks)<br> 1. Acceptability of ambulatory glucose profile system to patients<br> 2. Acceptability of ambulatory glucose profile system to family and carers (both informal and formal)<br> 3. Patient and carer experience<br>